Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric respiratory syncytial virus (RSV) infections in China. Addressing 12 clinical ...

The offering, the first IPO this year, attracted more than 32 billion dirhams ($3.5 bln) in demand for 500 million dirhams in shares. GSK seeks FDA nod for expanded use of RSV vaccine in adults ...

Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that ...

Pharmalittle: We’re reading about the gray market for obesity meds, an RSV drug recommendation, and more CDC advisory panel, selected by RFK Jr., recommends thimerosal be dropped from flu vaccines ...

GSK plc (GSK) said on Monday that its application for extending the use of its respiratory syncytial virus (RSV) vaccine ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

The University of Minnesota is stepping up efforts to identify biological threats that could trigger an epidemic, launching ...

The panel will hold two separate votes for the flu shot: one on influenza vaccines and another on influenza vaccines that contain thimerosal.

For decades, international researchers have received a small slice of the National Institutes of Health budget. In 2024, out ...

Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...